Emerging data suggests a link between GLP-1 weight loss drugs and increased risks of depression or suicidal ideation, similar to the quadrupled suicide risk seen after bariatric surgery. Experts suggest that removing food as a coping mechanism for emotional regulation can lead to psychological destabilization. Comparisons were made to the addictive nature of Oreos and cocaine, predicting a future wave of litigation against GLP-1 manufacturers.
